AAAAAA

   
Results: 1-10 |
Results: 10
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI Xanti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu
Authors: Schwaab, T Lewis, LD Cole, BF Deo, Y Fanger, MW Wallace, P Guyre, PM Kaufman, PA Heaney, JA Schned, AR Harris, RD Ernstoff, MS
Citation: T. Schwaab et al., Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI Xanti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu, J IMMUNOTH, 24(1), 2001, pp. 79-87
MHC class II expression and antigen presentation by human endometrial cells
Authors: Wallace, PK Yeaman, GR Johnson, K Collins, JE Guyre, PM Wira, CR
Citation: Pk. Wallace et al., MHC class II expression and antigen presentation by human endometrial cells, J STEROID B, 76(1-5), 2001, pp. 203-211
Development of an ELISA to measure soluble CD163 in biological fluids
Authors: Sulahian, TH Hintz, KA Wardwell, K Guyre, PM
Citation: Th. Sulahian et al., Development of an ELISA to measure soluble CD163 in biological fluids, J IMMUNOL M, 252(1-2), 2001, pp. 25-31
Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu
Authors: Lewis, LD Cole, BF Wallace, PK Fisher, JL Waugh, M Guyre, PM Fanger, MW Curnow, RT Kaufman, PA Ernstoff, MS
Citation: Ld. Lewis et al., Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu, J IMMUNOL M, 248(1-2), 2001, pp. 149-165
Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo
Authors: Wallace, PK Kaufman, PA Lewis, LD Keler, T Givan, AL Fisher, JL Waugh, MG Wahner, AE Guyre, PM Fanger, MW Ernstoff, MS
Citation: Pk. Wallace et al., Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo, J IMMUNOL M, 248(1-2), 2001, pp. 167-182
Exogenous antigen targeted to Fc gamma RI on myeloid cells is presented inassociation with MHC class I
Authors: Wallace, PK Tsang, KY Goldstein, J Correale, P Jarry, TM Schlom, J Guyre, PM Ernstoff, MS Fanger, MW
Citation: Pk. Wallace et al., Exogenous antigen targeted to Fc gamma RI on myeloid cells is presented inassociation with MHC class I, J IMMUNOL M, 248(1-2), 2001, pp. 183-194
Uptake of antigen-antibody complexes by human dendritic cells
Authors: Fanger, NA Guyre, PM Graziano, RF
Citation: Na. Fanger et al., Uptake of antigen-antibody complexes by human dendritic cells, METH MOL M, 64, 2001, pp. 377-386
Human monocytes express CD163, which is upregulated by IL-10 and identicalto p155
Authors: Sulahian, TH Hogger, P Wahner, AE Wardwell, K Goulding, NJ Sorg, C Droste, A Stehling, M Wallace, PK Morganelli, PM Guyre, PM
Citation: Th. Sulahian et al., Human monocytes express CD163, which is upregulated by IL-10 and identicalto p155, CYTOKINE, 12(9), 2000, pp. 1312-1321
Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice
Authors: Keler, T Guyre, PM Vitale, LA Sundarapandiyan, K van de Winkel, JGJ Deo, YM Graziano, RF
Citation: T. Keler et al., Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice, J IMMUNOL, 165(12), 2000, pp. 6738-6742
Antigen-presenting cells in the human female reproductive tract: Analysis of antigen presentation in pre- and post-menopausal women
Authors: Fahey, JV Prabhala, RH Guyre, PM Wira, CR
Citation: Jv. Fahey et al., Antigen-presenting cells in the human female reproductive tract: Analysis of antigen presentation in pre- and post-menopausal women, AM J REPROD, 42(1), 1999, pp. 49-57
Risultati: 1-10 |